Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects

NCT00580190 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
47
Enrollment
INDUSTRY
Sponsor class

Stopped Date of termination was Feb. 7, 2008. Reasons of termination were due to elevation of liver function tests and long elimination half-life of the compound.

Conditions

Interventions

Sponsor

Pfizer